EN | DE

Dr Christian Schütz

About

Dr. Christian Schütz studied chemistry at the Saarland University in Saabrücken, Germany, where he obtained his PhD in 2020 under the supervision of Prof. Dr. Rolf W. Hartmann and Dr. Martin Empting. His thesis dealt with the synthesis and optimization of novel quorum sensing inhibitors targeting PqsR. In December 2020 he joined the working group of Prof. Dr. Anna K. H. Hirsch as a Postdoc where he is involved in the synthesis and optimization of LasB inhibitors.


2021

A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms

Schütz C, Ho D, Hamed M, Abdelsamie A, Röhrig T, Herr C, Kany A, Rox K, Schmelz S, Siebenbürger L, …, Lehr C, Empting M (2021)

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (12)DOI: 10.1002/advs.202004369

2020

Novel PqsR Inverse Agonists

Hamed M, Ahmed S, Empting. M., Schütz C, Hartmann R, Röhrig T, Kany A, Hirsch A (2020)

Patent (EP20150119)

2018

Targeting the Pseudomonas quinolone signal quorum sensing system for the discovery of novel anti-infective pathoblockers

Schütz C, Empting M (2018)

Beilstein journal of organic chemistry 14: 2627-2645DOI: 10.3762/bjoc.14.241